← Back to Search

Behavioural Intervention

Interdisciplinary Management for Pediatric Musculoskeletal Disorders (PedEDmsk Trial)

N/A
Waitlist Available
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion an average of 4 weeks post-enrolment
Awards & highlights

PedEDmsk Trial Summary

This trial compares two methods of managing musculoskeletal complaints in kids ages 6-17. It will evaluate if delivering care in two methods is feasible and follow up with kids for 1 month.

Who is the study for?
This trial is for children and teens aged 6 to nearly 18 who come to the Montreal Children's Hospital Emergency Department with non-critical musculoskeletal issues. They must be able to speak French or English, have a low urgency score, and not have any serious conditions needing immediate attention.Check my eligibility
What is being tested?
The study compares usual care versus interdisciplinary management for handling kids' muscle and bone problems in the emergency department. It checks if these two approaches are practical by following up with patients for one month after their visit.See study design
What are the potential side effects?
Since this trial involves standard care procedures rather than medications, there aren't typical side effects like you'd see with drugs. However, different care methods may result in varying levels of comfort or recovery speed.

PedEDmsk Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion an average of 4 weeks post-enrolment
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion an average of 4 weeks post-enrolment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completed outcome measures
Rate of consent
Secondary outcome measures
Pain intensity on faces rating scale
Pain interference with function PROMIS scale

PedEDmsk Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterdisciplinaryExperimental Treatment1 Intervention
Interdisciplinary model for management of low acuity msk complaint
Group II: Usual careActive Control1 Intervention
usual care

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
447 Previous Clinical Trials
159,686 Total Patients Enrolled
1 Trials studying Musculoskeletal Disorders
8 Patients Enrolled for Musculoskeletal Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial encompass individuals older than thirty years of age?

"According to the entrance parameters, this trial is available for participants aged 6-17."

Answered by AI

Do any vacancies exist within this research endeavor?

"According to clinicaltrials.gov, this research trial is actively recruiting participants and its details have been updated as recently as October 3rd 2023 since being first posted on September 18th of the same year."

Answered by AI

Can I be included in the research experiment?

"To partake in this medical trial, individuals should be aged between 6 and 17 years old and have musculoskeletal pain. Approximately 60 candidates are desired for the study."

Answered by AI

How many people are taking part in this investigation?

"Affirmative. The clinical trial, which was first posted on September 18th 2023 is actively recruiting patients as indicated by the data hosted on clinicaltrials.gov. Sixty individuals are expected to take part in this single-site study that was last updated October 3rd 2023."

Answered by AI
~42 spots leftby Apr 2025